4.7 Review

Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases

期刊

DRUG DISCOVERY TODAY
卷 24, 期 3, 页码 873-882

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2019.01.006

关键词

-

资金

  1. National Institute of Health Grants NIH [R01DA037838, R01DA040537, R01DA034547, R01DA042706]
  2. Major State Basic Research Development Program of China [2017YFA0205201, 2014CB744503, 2013CB733802]
  3. National Natural Science Foundation of China [81422023, 81371596, 81672023, U1705281, U1505221]
  4. Fundamental Research Funds for the Central Universities [20720160065, 20720150141]
  5. Program for New Century Excellent Talents in University, China [NCET-13-0502]

向作者/读者索取更多资源

Advanced central nervous system (CNS) therapies exhibited high efficacy but complete treatment of CNS diseases remains challenging owing to limited delivery of therapeutic agents to the brain. Multifunctional magnetic nanoparticles are investigated not only for site-specific drug delivery but also for theranostic applications aiming for an effective CNS therapy. Recently, surface engineering of magnetic nanoparticles was recognized as a crucial area of research to achieve precise therapy and imaging at molecular and cellular levels. This review reports state-of-the-art advancement in the development of surface-engineered magnetic nanoparticles targeting CNS diagnostics and therapies. The challenges and future prospects of magnetic theranostics are also discussed by considering the translation from bench to bedside. Successful translation of magnetic theranostics to the clinical setting will enable precise and efficient diagnostics and therapy to manage CNS diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据